LivaNova Stock Soars 10.14% on Analyst Price Target Adjustment
1min read On April 8, 2025, LivaNova's stock surged by 10.14% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.
Barclays recently adjusted its price target for LivaNova, lowering it from $58.00 to $56.00 while maintaining an "equal weight" rating. This adjustment reflects the bank's updated outlook on the company's performance and potential.
Analysts have provided a range of price targets for LivaNova, with the average 12-month price target standing at $61.29. This target suggests a substantial upside potential of 70.49% from the current stock price. The highest price target among analysts is $74.00, while the lowest is $55.00, indicating a mix of optimistic and cautious views on the stock's future performance.
LivaNova has received a consensus rating of "Strong Buy" from analysts, with 6 buy ratings, 2 hold ratings, and no sell ratings. This strong buy recommendation is based on the company's recent financial performance and its outlook for future growth.
